Skip to main content
Archived articles

Voices+Opinion

Politics
White supremacy, political violence, and firearms
Published Nov 3, 2022
Policy experts, including U.S. Rep. Jamie Raskin, convene to discuss armed intimidation in the political process as Americans go to the polls for midterms
Voices
Commentary: It's time to stop creating 'superbugs' in the lab
Published Nov 1, 2022
Johns Hopkins computational biologist Steven Salzberg says Boston University study that created a new form of the omicron coronavirus variant should never have happened
Q+A
Expert warns of a 'tripledemic'
Published Oct 31, 2022
Now is the time to get your flu shots and bivalent boosters as hospitals and healthcare systems reach capacity with surging cases of flu, RSV, and COVID-19, says Brian Garibaldi of the Johns Hopkins Hospital Biocontainment Unit
Q+A
What's fueling Iran's ongoing protests?
Published Oct 24, 2022
A woman's suspicious death after being detained for an incorrectly worn hijab sends Iranians into the streets. SAIS expert Narges Bajoghli discusses the tumult.
Q+A
Study: EPA approach to assessing chemical health risks falls short
Published Oct 20, 2022
The Lautenberg Act was designed to shore up toxic substance safety assessments, but regulators are not using best practices, Johns Hopkins researcher finds
Q+A
On the frontlines of dissent
Published Oct 7, 2022
Zimbabwean activist Evan Mawarire, first dissident in residence at SNF Agora, speaks Oct. 11 on the Homewood campus
Q+A
Why and when to get a bivalent booster
Published Oct 6, 2022
The newly available COVID-19 boosters offer the best protection against current strains. But who needs it and when should they get it?
A father's wish, a bioethicist's dilemma
Published Fall 2022
A JHU faculty member recounts the agonizing decision he had to make for a parent unable to communicate with the world / Johns Hopkins Magazine
Q+A
What is 'quiet quitting'?
Published Sept 12, 2022
Rick Smith of the Carey Business School talks about what this TikTok buzzword really means for workers and workplaces
COVID-19 Vaccines
What you need to know about bivalent boosters for COVID-19
Published Sept 1, 2022
New booster shots designed to target the omicron variant and its subvariants, and the original strain of SARS-CoV-2, could become available in the U.S. in the coming weeks